Interleukin 27 and viral hepatitis: Smarter than the average cytokine

Hepatology

Volumn 50, Issue 2, 2009, Pages 358-360

  Laurence, Arian ^a   Klennerman, Paul ^b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 27; RIBAVIRIN; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; IL27 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; STAT PROTEIN;

ANTIINFLAMMATORY ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG TARGETING; EDITORIAL; HEPATITIS C; HUMAN; LIVER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; UPREGULATION; VIRUS HEPATITIS; VIRUS REPLICATION; ANIMAL; IMMUNOLOGY; METABOLISM; NOTE;

ANIMALS; HEPATITIS, VIRAL, HUMAN; HEPATOCYTES; HUMANS; INTERLEUKINS; STAT TRANSCRIPTION FACTORS;

EID: 68949181548     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23063     Document Type: Editorial

References (20)

1. Pearlman BL. Hepatitis C treatment update. Am J Med 2004;117:344-352.
2. Nelson DR, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu YL, et al. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. HEPATOLOGY 2003;38:859-868. (Pubitemid 37221669)
3. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001;194:1395-1406. (Pubitemid 33081515)
4. Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O'Shea JJ, et al. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 2003;23:147-161. (Pubitemid 36522792)
5. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008;453:1051-1057. (Pubitemid 351871737)
6. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-189. (Pubitemid 43214587)
7. Yao Z, Kanno Y, Kerenyi M, Stephens G, Durant L, Watford WT, et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 2007;109:4368-4375. (Pubitemid 46743405)
8. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008;9:641-649. (Pubitemid 351714729)
9. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. HEPATOLOGY 2004;40:1062-1071. (Pubitemid 39425561)
10. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007;27:647-659. (Pubitemid 47615503)
11. Stumhofer JS, Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008;117:123-130.
12. Bancroft AJ, Humphreys NE, Worthington JJ, Yoshida H, Grencis RK. WSX-1: a key role in induction of chronic intestinal nematode infection. J Immunol 2004;172:7635-7641. (Pubitemid 38747628)
13. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006;7:937-945. (Pubitemid 44263907)
14. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007;8:1363-1371. (Pubitemid 350131173)
15. Bender H, Wiesinger MY, Nordhoff C, Schoenher C, Haan C, Ludwig S, et al. Interleukin-27 displays interferon-γ-like functions in human hepatoma cells and hepatocytes. HEPATOLOGY 2009;50. doi:10.1002/hep.22988.
16. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791-796. (Pubitemid 41021213)
17. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005;437:1167-1172. (Pubitemid 41509355)
18. Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 2005;128:1437-1444. (Pubitemid 40712193)
19. Lapenta C, Santini SM, Spada M, Donati S, Urbani F, Accapezzato D, et al. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens. Eur J Immunol 2006;36:2046-2060. (Pubitemid 44251751)
20. Barnes E, Salio M, Cerundolo V, Medlin J, Murphy S, Dusheiko G, et al. Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrob Agents Chemother 2004;48:3382-3389. (Pubitemid 39129334)